Gulam Bahadur1,2, Roy Homburg2. 1. Reproductive Medicine Unit, North Middlesex University Hospital, Old Admin Block, Sterling Way, London N18 1QX, UK. 2. Homerton Fertility Unit, Homerton University Hospital, Homerton Row, London E9 6SR, UK.
Dear Editor,Prognostic factors in IUI analyses is a subject both topical and of importance if
pregnancy rates in IUI are to be improved. Although the recent retrospective study
(Sicchieri ) aims
to decipher the various contributors to IUI pregnancy rates, such as patient age, cause
of infertility, ovulation induction method, number of mature follicles and sperm with
progressive motility, the overall pregnancy rate of 7.59%/cycle was disappointing and
this may give a wrong perception of IUI practice. The UK IUI pregnancy rates averaged
around 13.5%/cycle and some clinics exceeding 20%/cycle. It also means that with every
100 women seeking first line treatment as IUI, 25-35% of the cohort will become pregnant
(Bahadur a). We
even demonstrated how it was possible to overcome the severe oligozoospermic effect by
utilising a consecutive ejaculate (Bahadur ). Crucial to IUI success was to switch over to
gonadotropin stimulated cycles, aiming for 2-3 follicles, but with a strict cancellation
policy to protect the patient from OHSS and multiple births. In more complex and older
patients, combination stimulation regimes can be tried. The cost-effective data clearly
shows that more pregnancies can occur with gonadotropin stimulated cycles (Peeraer ), or where
greater than 3 million motile progressive sperm are inseminated. Newer, well-constructed
RCT's provide further strong support for using IUI as first treatment option based on
high-quality evidence (Bensdorp ; Farquhar ; Nandi ). Sicchieri et al. (2018) rightly draw attention to
affordability issues in most parts of the world, and we now know that over 50% of women
undergoing IVF do not need IVF (Malchau ). The way forward is to achieve IUI pregnancies
earlier, paying attention to numerous prognostic factors and tailoring the stimulation
method for IUI. In particular, these are associated with the use of gonadotrophin
stimulation, having greater than 3 million motile progressive sperm in the insemination,
having 2-3 follicles, and above all ensuring safe practice against OHSS and multiple
births with a strict cancellation policy in place. Secondly, clinics should monitor
their outcomes in real time using a dedicated database. Our proposals should help steer
the global use of IUI towards a more effective and efficient first line treatment
option.
Authors: S S Malchau; A A Henningsen; A Loft; S Rasmussen; J Forman; A Nyboe Andersen; A Pinborg Journal: Hum Reprod Date: 2017-07-01 Impact factor: 6.918
Authors: Karen Peeraer; Jeroen Luyten; Carla Tomassetti; Sarah Verschueren; Carl Spiessens; Ann Tanghe; Christel Meuleman; Sophie Debrock; Eline Dancet; Thomas D'Hooghe Journal: Reprod Biomed Online Date: 2017-12-27 Impact factor: 3.828
Authors: A J Bensdorp; R I Tjon-Kon-Fat; P M M Bossuyt; C A M Koks; G J E Oosterhuis; A Hoek; P G A Hompes; F J M Broekmans; H R Verhoeve; J P de Bruin; R van Golde; S Repping; B J Cohlen; M D A Lambers; P F van Bommel; E Slappendel; D Perquin; J M Smeenk; M J Pelinck; J Gianotten; D A Hoozemans; J W M Maas; M J C Eijkemans; F van der Veen; B W J Mol; M van Wely Journal: BMJ Date: 2015-01-09
Authors: Fernanda Sicchieri; Aline Bomfim Silva; Ana Carolina Japur de Sá Rosa E Silva; Paula Andrea de Albuquerque Sales Navarro; Rui Alberto Ferriani; Rosana Maria Dos Reis Journal: JBRA Assist Reprod Date: 2018-03-01